Executive Summary
A single significant $108M contract modification awarded to CGI Federal Inc. (Timken subsidiary) for EPA IT enterprise development signals strong federal demand in IT services, with potential expansion to $523M via options through 2030. This bullish development underscores GSA's reliance on cost-plus structures for environmental agency tech support.
Investors should monitor option exercises amid execution risks from subawards and performance fees.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from March 27, 2026.
Investment Signals (1)
- $108M GSA Mod for EPA IT Upside to $523M (HIGH)▲
CGI Federal secures cost-plus award fee delivery order with $108M obligated and $522M potential value through 2030 for computer systems design.
Risk Flags (1)
- Execution [MEDIUM RISK]▼
Options may not exercise beyond 2026, performance-based award fees, and $15M subawards across 47 recipients could erode margins.
Opportunities (1)
- ◆
Full $523M value via option exercises and GSA task order expansions in EPA IT support.
Sector Themes (1)
- ◆
GSA leverages cost-plus contracts for EPA enterprise IT, with long-duration potential to 2030.
Watch List (2)
- 👁
{"entity"=>"CGI Federal Inc.", "reason"=>"Key player in GSA/EPA IT with $523M pipeline at risk of partial exercise.", "trigger"=>"Option exercises or new FEDSIM task orders >$50M"}
- 👁
{"entity"=>"The Timken Company", "reason"=>"Parent exposure to federal IT via CGI subsidiary's large mod.", "trigger"=>"Earnings impact from contract revenue or subaward costs"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Significant Contract Modifications ($10M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals